Genta-Aventis Case Study: Failing Strategies Within Late Stage Vertical Licensing
| Natura: | Elettronico Periodico |
|---|---|
| Lingua: | inglese |
| Pubblicazione: |
MarketLine, a Progressive Digital Media business
|
| Accesso online: | Full text available on EBSCOhost[Nov 2005-Nov 2005 |
Documenti analoghi
IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
Roche-Kosan Case Study: Successful Early Licensing Strategies
Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
Aventis SWOT Analysis
Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio
Sanofi-Aventis SWOT Analysis
Licensing Loyalty
di: McLeod
di: McLeod
License to Play
di: Daliot-Bul
di: Daliot-Bul
License to Wed
di: Richman
di: Richman
Licensing Journal
Failing Families, Failing Science
di: Lincoln
di: Lincoln
Licensed Practical Nurse
Vertical Reefs
di: Wicksten
di: Wicksten
Lipitor Case Study: Lifecycle Management Strategies
Failed Frontiersmen
di: Donahue
di: Donahue
Words Fail
di: Dickinson
di: Dickinson
The Revolution that Failed
di: Fairclough
di: Fairclough
Failed Evidence
di: Harris
di: Harris
Failed Promises
di: Konisky
di: Konisky
IPO Exit Strategies Case Study: Undertaking a Successful IPO Exit Strategy
Staging Harmony
di: Brokaw
di: Brokaw
Staging Asia
di: Kuruppath
di: Kuruppath
Setting the Stage
di: Hays
di: Hays
Subversive Stages
di: Komporaly
di: Komporaly
Staging Revolution
di: Fan
di: Fan
Occupying the Stage
di: Bredeson
di: Bredeson
Staging Family
di: Mullenneaux
di: Mullenneaux
Staging the Amistad
di: Christensen
di: Christensen
On Stage Alone
di: Gitelman
di: Gitelman
Staging Ghana
di: Schauert
di: Schauert
Stage for Action
di: Dail
di: Dail
The Stages of Memory
di: Young
di: Young
Documenti analoghi
- IDEC-Genentech Case Study: Successful Late Stage Licensing Strategies
- Roche-Kosan Case Study: Successful Early Licensing Strategies
- Forest Laboratories & Schering-Plough Case Studies: Pharmaceutical Licensing Strategies
- Aventis SWOT Analysis
- Sanofi-Aventis Case Study: Building a Successful Insulin Portfolio